Graviton BioScience

Biotechnology
$68.3Mtotal raised · 3 rounds on record
$25Mlatest round · Venture round · Nov 2023 · 2 yr ago
200+team · employees, estimated range
2020founded

Overview

About Us Graviton Biosciences Corporation > About Us Print Spread the love The essence of Graviton is that we are comprised of thought leaders who identify, research, and demonstrate the therapeutic potential of novel molecular and cellular pathways pathways.

Funding and backers

Total raised
$68.3M
3 rounds on record
Latest round
$25M
Venture round · Nov 2023 · 2 yr ago
Team
201-500
employees, estimated range
The money's age
Long since its last round
35 months since the last round · not hiring
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Nov 22, 2023 Raised a round Venture round $25M · SEC Form D Dec 20, 2022 Raised a round Venture round $39.8M · SEC Form D Feb 4, 2021 Raised a round Venture round $3.5M · SEC Form D 2020 Founded
Funding rounds
RoundDateAmountInvestorsSource
Venture round Nov 2023 $25M — SEC Form D
Venture round Dec 2022 $39.8M — SEC Form D
Venture round Feb 2021 $3.5M — SEC Form D
Registers and programsofficial lists and records that name the company
Legal entity Graviton BioScience Corp SEC Form D
Founders and leadersfrom filings, registers and the company's site
Samuel WaksalExecutive Officer, DirectorSEC Form D
Investors in similar startupsfunds that back the companies most like this one
Antler
backs Rainmaker
RA Capital Management
backs Forward Therapeutics
OrbiMed
backs Forward Therapeutics
Elevate Ventures
backs Attend
Source Code Capital
backs Starnatx
TechFW | Tech Fort Worth
backs MOOVFORWARD
Similar startupsby what they do, their industry and backers
Fluxon201-500 employees · 9 roles
Fluxon is a global product development company comprised of tech-leaders from Google, Stripe, and top startups trusted by the most…
Attend11-50 employees
Attend captures the essence of connection, bringing people, moments, and memories together with one platform.
SyntisVenture round $25M · 16 mo ago · Founded 2022 · 51-200 employees
Syntis Bio is unlocking the full therapeutic potential of the small intestine. Revolutionizing oral therapy for obesity, rare diseases, &…
Forward TherapeuticsVenture round $50M · 2 yr ago
Forward, by Design.. Novel chemistry. Proven pathways. Designed for patient impact.
MOOVFORWARD
Discover the essence of MoovForward – where style meets productivity. Learn about our commitment to quality work bags that enhance your…
Rainmaker
... Search Here .... Unleash the Potential of Every Agent with Rainmaker's AI.

Visa sponsorship

United StatesUS 0
0
H-1B filings in 12 months
0
Open roles in United States
In the register as Graviton Bioscience Corporation, New York, NY
Other sponsors in the same field
Regeneron Pharmaceuticals 316 filingsHoneywell 150 filingsIQVIA 140 filingsDeltacomputerconsulting 28 filings
Alert me
US Department of Labor · latest filing Jun 13, 2025 · Visa details by country

Financials

Total raised
$68.3M
Latest round
Venture - Series Unknown
Funding rounds
3
Funding rounds
Round Announced Amount
Venture - Series Unknown 2023 $25M Details
Venture - Series Unknown 2022 $39.8M Details
Venture - Series Unknown 2021 $3.5M Details

People

Samuel Waksal
Executive Officer, Director
SEC Form D
Bihua Chen
Director
SEC Form D
Stelios Papadopoulos
Director
SEC Form D
Jeremy Levin
Director
SEC Form D
David MacMillan
Director
SEC Form D
Ran Nussbaum
Director
SEC Form D
James Boylan
Director
SEC Form D
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
New York United States
HQ
Contact Us
200-500 est. staff
450 East 29th Street, New York, New York 10016
company site